A study to compare the effectiveness of Mustasadhita Takra Basti and Takra Basti in Grahani/ Irritable Bowel Syndrome.

A randomized open labelled comparative clinical study to evaluate the efficacy of Musta Sadhita Takra Basti and Takra Basti in Grahani vis-à-vis Irritable Bowel Syndrome. - NIL

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/056529

Enrollment

Registered

2023-08-16

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K582- Mixed irritable bowel syndrome

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: ? Subjects between the age group of 21 – 65 years irrespective of gender, religion, occupation and socioeconomic status. ? Subjects fit for Basti. ? Subjects fulfilling the Rome IV diagnostic criteria for IBS. ? Subjects who are willing to give a written consent for the treatment

Exclusion criteria

Exclusion criteria: ? Subjects below 21 years and above 65 years of age. ? Subjects unfit for Basti. ? Condition associated with inflammatory bowel disease, and other systemic illnesses that interfere with the treatment protocol. ? Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
Baddha Mala Pravritti, Drava Mala Pravritti, Muhur Muhur Mala Pravritti, Gas or Flatulence, Udara Shoola or Discomfort, Amayukta Mala Pravritti or Mucus in stoolTimepoint: 1st, 9th & 28th day	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Madhushree H S

Sri Sri College of Ayurvedic Science and Research

drmadhushreehs@rediffmail.com9916058006

Outcome results